The findings come from the first and only decentralized real-world study examining how HD chorea affects patients and caregivers and how treatment impacts quality of life
Visakhapatnam-based hospital reaches major milestone in robotic orthopaedics, helping patients across North Andhra Pradesh and Odisha regain mobility through precision-assisted knee replacement procedures.
Bolstering neuroscience push with late-stage Tourette therapy
The filing is backed by positive Phase 3 results recently published in JAMA Neurology
The safety profile of the Lunsumio and Polivy combination was consistent with the known profiles of the individual study medicines
The company said the safety profile remained consistent with earlier studies and was considered manageable
Under the agreement, Apogee shareholders will receive $135.11 per share in cash, and the transaction has been unanimously approved by both companies’ boards
The FDA has granted Priority Review, setting a target decision date of 9 October 2026, potentially accelerating access to a new treatment option for a subset of patients with high-risk colon cancer characterized
.jpeg)
One of our major priorities in next 3-5 years is the introduction of a kit-based version of CanAssist Breast, enabling hospitals conduct the test locally
CEO Stéphane Bancel framed the changes as essential to scaling the business
Subscribe To Our Newsletter & Stay Updated
